Skip to content

N-[[6-(3,5-dimethylpyrazol-1-yl)-3-pyridinyl]methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine-5-carboxamide

C19H21N5OS — CID 136577383

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACN-[[6-(3,5-dimethylpyrazol-1-yl)-3-pyridinyl]methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine-5-carboxamide
SMILESCc1cc(C)n(-c2ccc(CNC(=O)N3CCc4sccc4C3)cn2)n1
InChIInChI=1S/C19H21N5OS/c1-13-9-14(2)24(22-13)18-4-3-15(10-20-18)11-21-19(25)23-7-5-17-16(12-23)6-8-26-17/h3-4,6,8-10H,5,7,11-12H2,1-2H3,(H,21,25)
InChIKeyCFZBICIHRPMQEE-UHFFFAOYSA-N
MW367.48 g/mol
LogP3.21
Rot. Bonds3

About N-[[6-(3,5-dimethylpyrazol-1-yl)-3-pyridinyl]methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine-5-carboxamide

N-[[6-(3,5-dimethylpyrazol-1-yl)-3-pyridinyl]methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine-5-carboxamide (PubChem CID 136577383) has the molecular formula C19H21N5OS and a molecular weight of 367.48 g/mol. Its IUPAC name is N-[[6-(3,5-dimethylpyrazol-1-yl)-3-pyridinyl]methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine-5-carboxamide.

Molecular Properties

Compound NameN-[[6-(3,5-dimethylpyrazol-1-yl)-3-pyridinyl]methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine-5-carboxamide
PubChem CID136577383
Molecular FormulaC19H21N5OS
Molecular Weight367.48 g/mol
Exact Mass367.15
IUPAC NameN-[[6-(3,5-dimethylpyrazol-1-yl)-3-pyridinyl]methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine-5-carboxamide
SMILESCc1cc(C)n(-c2ccc(CNC(=O)N3CCc4sccc4C3)cn2)n1
InChIInChI=1S/C19H21N5OS/c1-13-9-14(2)24(22-13)18-4-3-15(10-20-18)11-21-19(25)23-7-5-17-16(12-23)6-8-26-17/h3-4,6,8-10H,5,7,11-12H2,1-2H3,(H,21,25)
InChIKeyCFZBICIHRPMQEE-UHFFFAOYSA-N
XLogP3.21
TPSA63.05 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds3
Heavy Atoms26
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500367.48
LogP ≤ 53.21
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze N-[[6-(3,5-dimethylpyrazol-1-yl)-3-pyridinyl]methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[[6-(3,5-dimethylpyrazol-1-yl)-3-pyridinyl]methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine-5-carboxamide?
The IUPAC name of N-[[6-(3,5-dimethylpyrazol-1-yl)-3-pyridinyl]methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine-5-carboxamide (CID 136577383) is N-[[6-(3,5-dimethylpyrazol-1-yl)-3-pyridinyl]methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine-5-carboxamide.
What is the SMILES notation for N-[[6-(3,5-dimethylpyrazol-1-yl)-3-pyridinyl]methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine-5-carboxamide?
The canonical SMILES for N-[[6-(3,5-dimethylpyrazol-1-yl)-3-pyridinyl]methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine-5-carboxamide is Cc1cc(C)n(-c2ccc(CNC(=O)N3CCc4sccc4C3)cn2)n1.
What is the InChIKey of N-[[6-(3,5-dimethylpyrazol-1-yl)-3-pyridinyl]methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine-5-carboxamide?
The InChIKey is CFZBICIHRPMQEE-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H21N5OS/c1-13-9-14(2)24(22-13)18-4-3-15(10-20-18)11-21-19(25)23-7-5-17-16(12-23)6-8-26-17/h3-4,6,8-10H,5,7,11-12H2,1-2H3,(H,21,25).
What are the key properties of N-[[6-(3,5-dimethylpyrazol-1-yl)-3-pyridinyl]methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine-5-carboxamide?
N-[[6-(3,5-dimethylpyrazol-1-yl)-3-pyridinyl]methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine-5-carboxamide has a molecular weight of 367.48 g/mol, XLogP of 3.21, 3 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[6-(3,5-dimethylpyrazol-1-yl)-3-pyridinyl]methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine-5-carboxamide is sourced from PubChem (CID 136577383), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.